Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Pulmonary Alveolar Proteinosis

• Study of Human Bone Marrow Mesenchymal Stem Cells in aPAP
• Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
• Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection
• Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene.
• Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis
• Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis
• Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis
• Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis
• SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study
• Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan
• Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
• Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects
• Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)
• Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.
• Rituximab for Anti-cytokine Autoantibody-Associated Diseases
• Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP)
• Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (PAP)
• Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis
• GM-CSF in Patients With Pulmonary Alveolar Proteinosis